Elder Pharma Of India To Gain Control Of U.K.’s NeutraHealth
This article was originally published in PharmAsia News
Executive Summary
India's Elder Pharmaceuticals plans to increase its one-fifth share in U.K.-based NeutraHealth to give Elder a presence in that market. Elder seeks to increase its share in the company to 60 percent, well beyond the 20 percent share it bought two years ago. Elder's international director said the buy is seen as giving the firm greater access not only to the U.K., but also to other European countries. Elder plans to market NeutraHealth brands in the U.K. along with its own medicines. (Click here for more